Cas:35661-39-3 Fmoc-Ala-OH manufacturer & supplier

Chemical Name:Fmoc-Ala-OH

CAS.NO:35661-39-3

Synonyms:N-[(9H-Fluoren-9-ylMethoxy)carbonyl]-L-alanine Hydrate;Fmoc-Ala-OH Hydrate;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)propanoic acid;9-fluorenylmethoxycarbonyl-Ala-OH;N-((9H-Fluoren-9-ylmethoxy)carbonyl)-L-alanine;Fmoc-L-alpha-Alanine;EINECS 252-660-6;MFCD00037139;L-Alanine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-;Fmoc-L-alanine Hydrate;Fmoc-Ala-OH;Fmoc-L-Alanine;N-(9-Fluorenylmethoxycarbonyl)-L-alanine,Fmoc-L-alanine;(2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}propanoic acid;9-Fmoc-L-alanine;N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-alanine;N-Fmoc-L-alanine;Fmoc-Ala-OH| Fmoc-L-Ala-OH;Fmoc-β-Ala-OH

Molecular Formula:C₁₈H₁₇NO₄

Molecular Weight:311.332

HS Code:2924299090

Physical and Chemical Properties:

Melting point:150-154ºC

Boiling point:544.1±33.0 °C at 760 mmHg

Density:1.3±0.1 g/cm3

Index of Refraction:1.608

PSA:79.12000

Exact Mass:311.115753

LogP:3.54

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like N-[(9H-Fluoren-9-ylMethoxy)carbonyl]-L-alanine Hydrate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Fmoc-β-Ala-OH physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00037139 Use and application,Fmoc-β-Ala-OH technical grade,usp/ep/jp grade.

Related News: It found that about 5% of both groups of women have a genetic mutation that increases the risk of breast cancer. Fmoc-Ala-OH manufacturer South Korea said on Sunday that it would deny entry to any foreigners who have traveled to Wuhan and surrounding Hubei Province in China in the past 14 days. Fmoc-Ala-OH supplier He said the FDA made its decision by fiat, and had not asked its advisors to consider whether the drug’s ability to remove a type of brain plaques known as beta amyloid would improve outcomes for patients. Fmoc-Ala-OH vendor Catalent��s clinical supply network includes nine cGMP-certified clinical packaging facilities across North America, Europe and Asia, and more than 50 strategically-located depots around the world, providing local and regional options for clinical storage, distribution, expiry update and relabeling services, and clinical returns management. Fmoc-Ala-OH factory Today’s decisions represent progress in our continued efforts to make a difference in this pandemic on a global scale, Kathy Wengel, J&J’s chief global supply chain officer, said in the statement.